Official Committee of Unsecured Creditors of Crystal Medical Products, Inc. v. Houpt (In Re Crystal Medical Products, Inc.)

240 B.R. 290, 1999 Bankr. LEXIS 1347, 1999 WL 985139
CourtUnited States Bankruptcy Court, N.D. Illinois
DecidedOctober 29, 1999
Docket19-02655
StatusPublished
Cited by19 cases

This text of 240 B.R. 290 (Official Committee of Unsecured Creditors of Crystal Medical Products, Inc. v. Houpt (In Re Crystal Medical Products, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Official Committee of Unsecured Creditors of Crystal Medical Products, Inc. v. Houpt (In Re Crystal Medical Products, Inc.), 240 B.R. 290, 1999 Bankr. LEXIS 1347, 1999 WL 985139 (Ill. 1999).

Opinion

MEMORANDUM OPINION ON PLAINTIFF’S MOTION FOR SUMMARY JUDGMENT

ERWIN I. KATZ, Bankruptcy Judge.

This adversary case is a core proceeding in the bankruptcy filed by Crystal Medical Products, Inc. (“CMP”) under Chapter 11 of the Bankruptcy Code, 11 U.S.C. § 101, et seq. The Official Committee of Unsecured Creditors of CMP (“Committee”) has filed a complaint to avoid and recover two prepetition transfers made by CMP to Pedersen & Houpt (“P & H”).

*294 This matter comes before the Court on Plaintiffs Motion for Summary Judgment. Both parties have submitted statements of material fact as to which there is no dispute under Local Rule 402.

JURISDICTION & VENUE

The Court has jurisdiction over this matter pursuant to 28 U.S.C. § 1334, and Local General Rule 2.33(A) of the United States District Court for the Northern District of Illinois. This matter is a core proceeding pursuant to 28 U.S.C. § 157(b)(2)(F). Venue ' lies under 28 U.S.C. § 1409.

BACKGROUND

The following undisputed facts were taken from the 402(M) and 402(N) statements, the responses thereto and the affidavits submitted by the parties:

CMP is a company engaged in the business of developing immunoassay technology and selling medical devices. CMP’s troubles began with its Board of Directors and certain officers, who were led by Orvin “Skip” Nordness, Jr. (“Nordness”), CMP’s largest shareholder. Nordness engaged in a course of conduct harmful to the business by grossly mismanaging CMP’s assets; he failed to pay payroll withholding taxes for three years and federal corporate income tax for two years, attempted to use company funds to purchase an automobile dealership, unrelated to CMP’s business and fraudulently converted over $100,000 in company cash to his own accounts. In 1995, CMP was evicted from its offices and operations were at a standstill. Also in 1995, shareholders of CMP filed a derivative suit, attempting to remove the current directors and officers. The shareholders retained P & H as their attorneys to prosecute the derivative suit. In February 1996, the suit was settled and as part of the settlement, certain board members, including Nordness, were forced to resign from CMP’s board of directors.

The new board passed a resolution for the corporation to pay the P & H legal fees incurred by the shareholders. After new directors were elected, they retained P & H in a variety of matters including litigation, corporate and financing matters, and P & H counseled the CMP board on the board’s efforts to obtain financing. P & H invoiced CMP for work performed.

In the course of pursuing financing, certain shareholders of CMP formed KingCo, L.L.C. (“KingCo”). KingCo agreed to provide CMP with a $1,200,000 line of credit. CMP actually borrowed $585,000 from KingCo, pursuant to a note and related security and credit agreements; this loan was secured by substantially all of CMP’s assets. The loan proceeds were then distributed to certain vendors, service providers and professionals who had delivered services to CMP.

P & H was one of the creditors paid with the loan proceeds; P & H received two cashier’s checks from CMP totaling $100,000 and deposited them into its bank account on May 23, 1996. $54,862.75 (“claim portion”) of this amount was applied by P & H to an outstanding invoice for services rendered and fees incurred on behalf of CMP itself, and $45,137.25 (“shareholder portion”) of the payment was applied to an outstanding invoice for services rendered and fees incurred on behalf of CMP shareholders.

On May 24, 1996, CMP filed its Chapter 11 petition. Plaintiff filed its adversary complaint on May 21, 1998. On January 15, 1999, the Committee served P & H with requests for admission, to which P & H did not timely respond. The Committee moved for summary judgment on May 7, 1999. On June 23, 1999, P & H moved for leave to file its answers to the request for admissions, to which it attached the answers. This Court will allow late filing of the answers and has considered them in deciding on this motion. The Court will consider assessment of costs and fees incurred by the Committee against P & H due to late filing.

*295 The Committee alleges that the prepetition transfer made by CMP to P & H totaling $100,000 is avoidable. In Count I of its complaint, the Committee alleges that the claim portion of the payment is avoidable under § 547(b) as a preference. In Count II, the Committee asserts that the claim portion of the payment was a fraudulent transfer within the meaning of 740 ILCS 160/5 and 160/6, and that the payment may be avoided under § 544(b). Finally, in Count III, the Committee alleges that it may avoid the shareholder portion of the payment pursuant to § 548.

P & H, however, contends that the funds loaned by KingCo to CMP were earmarked for payment of fees owed to P & H and therefore were never property of the estate. P & H also argues that the-Committee cannot avoid the payment as a preference because, pursuant to § 547(c)(1) there was a contemporaneous exchange for new value and the transfer was made in the ordinary course of business, thus qualifying for protection from avoidance under § 547(c)(2). P & H also asserts that there are numerous issues of material fact as to the fraudulent transfer claims.

The Committee’s motion for summary judgment is denied.

DISCUSSION

I. Standards for Summary Judgment

The purpose of summary judgment under Federal Rule of Civil Procedure 56 (adopted by Federal Rule of Bankruptcy Procedure 7056) is to avoid unnecessary trials when there is no genuine issue of material fact. Farries v. Stanadyne/Chicago Div., 832 F.2d 374, 378 (7th Cir.1987), Wainwright Bank & Trust Co. v. Railroadmens Federal Sav. & Loan Ass’n of Indianapolis, 806 F.2d 146, 149 (7th Cir.1986). Summary judgment is proper if the pleadings, depositions, answers to interrogatories, and admissions on file, together with any affidavits, show that there is no genuine issue of material fact and that the moving party is entitled to judgment as. a matter of law. Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S.Ct. 2548, 2552, 91 L.Ed.2d 265 (1986), Matsushita Elec. Indus. Co., Ltd. v. Zenith Radio Corp.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Walters v. Stevens, Littman, Biddison
971 F.3d 1209 (Tenth Circuit, 2020)
Stuart v. Commissioner
144 T.C. No. 12 (U.S. Tax Court, 2015)
Michaely v. Frey CA2/1
California Court of Appeal, 2014
Alberts v. HCA, Inc.
496 B.R. 1 (District of Columbia, 2013)
Bertram v. WFI STADIUM, INC.
41 A.3d 1239 (District of Columbia Court of Appeals, 2012)
Cordes & Company, LLC v. Mitchell Companies, LLC
605 F. Supp. 2d 1015 (N.D. Illinois, 2009)
Grochocinski v. Zeigler (In Re Zeigler)
320 B.R. 362 (N.D. Illinois, 2005)
Krol v. Wilcek (In Re H. King & Associates)
295 B.R. 246 (N.D. Illinois, 2003)
Mejia v. Reed
118 Cal. Rptr. 2d 415 (California Court of Appeal, 2002)
Silagy v. Gagnon (In Re Gabor)
280 B.R. 149 (N.D. Ohio, 2002)
Helms v. Roti (In Re Roti)
271 B.R. 281 (N.D. Illinois, 2002)
Manchester v. First Bank & Trust Co. (In Re Moses)
256 B.R. 641 (Tenth Circuit, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
240 B.R. 290, 1999 Bankr. LEXIS 1347, 1999 WL 985139, Counsel Stack Legal Research, https://law.counselstack.com/opinion/official-committee-of-unsecured-creditors-of-crystal-medical-products-inc-ilnb-1999.